These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6792691)

  • 41. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
    Situnayake RD; McConkey B
    J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs.
    Taha AS; Capell HA; Sturrock RD; Russell RI
    Am J Gastroenterol; 1991 Nov; 86(11):1588-91. PubMed ID: 1683150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in the treatment of rheumatic diseases.
    Jayson MI
    Practitioner; 1973 Oct; 211(264):483-90. PubMed ID: 4583810
    [No Abstract]   [Full Text] [Related]  

  • 44. Gastric retention of enteric-coated aspirin tablets in beagle dogs.
    Nap RC; Breen DJ; Lam TJ; De Bruyne JJ
    J Vet Pharmacol Ther; 1990 Jun; 13(2):148-53. PubMed ID: 2384905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyloric stenosis: hold-up of enteric coated aspirin tablets.
    Harris FC
    Br J Surg; 1973 Dec; 60(12):979-81. PubMed ID: 4764749
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment.
    Morris AD; Holt SD; Silvoso GR; Hewitt J; Tatum W; Grandione J; Butt JH; Ivey KJ
    Scand J Gastroenterol Suppl; 1981; 67():131-5. PubMed ID: 6941392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rheumatoid arthritis: limiting the damage.
    Hosie G
    Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
    [No Abstract]   [Full Text] [Related]  

  • 49. Fatal iatrogenic salicylate intoxication in a long-term user of enteric-coated aspirin.
    Shkrum MJ; Gay RM; Hudson P
    Arch Pathol Lab Med; 1989 Jan; 113(1):89-90. PubMed ID: 2910232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E; Kåss E
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of drugs in rheumatic diseases.
    Gall EP
    Prim Care; 1984 Jun; 11(2):369-80. PubMed ID: 6433371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of three slow-release acetylsalicylic acid preparations in rheumatoid arthritis.
    Martio J; Kahela P
    Scand J Rheumatol; 1983; 12(3):305-9. PubMed ID: 6623020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Salicylate dosage for children with juvenile chronic arthritis].
    Mäkelä AL; Yrjänä T
    Duodecim; 1978; 94(12):771-9. PubMed ID: 357138
    [No Abstract]   [Full Text] [Related]  

  • 55. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
    Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
    Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
    [No Abstract]   [Full Text] [Related]  

  • 57. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salicylate therapy and drug interaction in rheumatoid arthritis.
    Barraclough DR; Muirden KD; Laby B
    Aust N Z J Med; 1975 Dec; 5(6):518-23. PubMed ID: 1065285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.
    Dixon JS; Pickup ME; Lowe JR; Hallett C; Lee MR; Wright V
    Ann Rheum Dis; 1980 Aug; 39(4):301-11. PubMed ID: 7436556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.
    Hurst NP; Bell AL; Nuki G
    Ann Rheum Dis; 1986 Jan; 45(1):37-43. PubMed ID: 3006610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.